← Leaderboards
Kenneth Mathew Zangwill
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center
$1,087,086
Attributed
$1,087,086
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $655.7K · FY2006–15$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$987,086 · 8
AHRQ$100,000 · 1
By mechanism
M01$987,086 · 8
R03$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center
Same institution · by research overlap
- Christina Wang$22,207,274
- Jocelyn S Tsuang$185,357
- Chrisanna Mink$259,162
- Soula Athanasia Danopoulos$3,528,232
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesResearch PersonnelSafetyUnited States National Institutes Of HealthDoseAdultPlacebosResourcesGrantSourceInfluenza Virus VaccineInfluenza A Virus, H5n1 SubtypeInstitutionFundingAntibodiesParticipantComputer Retrieval Of Information On Scientific Projects DatabaseIntramuscular InjectionsClinicLaboratoriesDouble-Blind MethodAge-YearsOralBlood Specimen
Grant awards (9)
Study of the Trends in Evaluation and Management of the Young Febrile Infant and its Related Healthcare Costs and Morbidities$100,000
R03 · FY2015 · HS · contact PI
CLINICAL TRIAL: A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE I/II, DO$34,356
M01 · FY2008 · RR · contact PI
OPEN-LABEL STUDY OF INTRAMUSCULAR INACTIVATED INFLUENZA A/H5N1 VACCINE IN HEA$23,391
M01 · FY2008 · RR · contact PI
A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE I/II, DOSE-RANGING STUDY$129,964
M01 · FY2007 · RR · contact PI
EVALUATION OF A BOOSTER DOSE OF A/VIETNAM/1203/04 (H5N1) VACCINE ADMINISTERED$102,605
M01 · FY2007 · RR · contact PI
A/H5N1 VACCINE PHASE I/II STUDY IN HEALTHY ADULTS$41,043
M01 · FY2007 · RR · contact PI
A/H5N1 VACCINE PHASE I/II STUDY IN HEALTHY ADULTS$552,880
M01 · FY2006 · RR · contact PI
A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE I/II, DOSE-RANGING STUDY$91,627
M01 · FY2006 · RR · contact PI
EVALUATION OF A BOOSTER DOSE OF A/VIETNAM/1203/04 (H5N1) VACCINE ADMINISTERED$11,220
M01 · FY2006 · RR · contact PI